spinoffs

As Sandoz prepares to spin off from Novartis, the company sets sights on new crosstown headquarters
As Sandoz prepares to spin off from Novartis, the company sets sights on new crosstown headquarters
Fierce Pharma
Novartis
biosimilars
spinoffs
headquarters
Flag link:
Does Johnson & Johnson's Kenvue Spinoff Make Sense?
Does Johnson & Johnson's Kenvue Spinoff Make Sense?
Motley Fool
JNJ
consumer health
spinoffs
Kenvue
Flag link:
Johnson & Johnson consumer health unit valued at $40 billion ahead of IPO, report says
Johnson & Johnson consumer health unit valued at $40 billion ahead of IPO, report says
CNBC
JNJ
consumer health
IPOs
Kenvue
spinoffs
Flag link:
Icahn pushes for spinoff of Illumina’s Grail division
Icahn pushes for spinoff of Illumina’s Grail division
BioPharma Dive
Illumina
Grail
Carl Icahn
M&A
spinoffs
Medtech
diagnostics
Flag link:
Bayer's incoming CEO Anderson won't rule out consumer, agriculture spinoffs: report
Bayer's incoming CEO Anderson won't rule out consumer, agriculture spinoffs: report
Fierce Pharma
Bayer
Bill Anderson
Pharma CEOs
spinoffs
consumer health
Flag link:
Sanofi attempting to spin off consumer health unit in India: report
Sanofi attempting to spin off consumer health unit in India: report
Fierce Pharma
Sanofi
consumer health
India
spinoffs
Flag link:
Medtronic’s Chan talks patient monitoring spinoff, rise of home care
Medtronic’s Chan talks patient monitoring spinoff, rise of home care
Medtech Dive
Medtronic
Medtech
patient monitoring
spinoffs
restructuring
Flag link:
Ready for takeoff: J&J's consumer health unit Kenvue files for official separation
Ready for takeoff: J&J's consumer health unit Kenvue files for official separation
Endpoints
JNJ
IPOs
consumer health
Kenvue
spinoffs
Flag link:
This Biopharma Offspring Is All Grown Up
This Biopharma Offspring Is All Grown Up
Medical Devices and Diagnostics Industry
Abbott Labs
spinoffs
AbbVie
Flag link:
Alkermes to hive off oncology business
Alkermes to hive off oncology business
Pharma Letter
Alkermes
oncology
spinoffs
Flag link:
Medtronic to Part Ways with Two Key Businesses
Medtronic to Part Ways with Two Key Businesses
Medical Devices and Diagnostics Industry
Medtronic
Medtech
spinoffs
patient monitoring
Respiratory
Flag link:
Johnson & Johnson taps Scottish inspiration in branding its consumer spinoff
Johnson & Johnson taps Scottish inspiration in branding its consumer spinoff
Fierce Pharma
JNJ
branding
Kenvue
consumer health
spinoffs
Flag link:
GE Reveals Date for Healthcare Spinoff
GE Reveals Date for Healthcare Spinoff
Medical Devices and Diagnostics Industry
GE
GE Healthcare
spinoffs
Medtech
Flag link:
It's a spinoff: Novartis parts ways with Sandoz just as its generics biz shows signs of recovery
It's a spinoff: Novartis parts ways with Sandoz just as its generics biz shows signs of recovery
Fierce Pharma
spinoffs
Novartis
Sandoz
generics
Flag link:
LabCorp plans to break out its $6B drug development biz as a standalone company
LabCorp plans to break out its $6B drug development biz as a standalone company
MedCity News
LabCorp
diagnostics
drug development
spinoffs
Flag link:
Why GlaxoSmithKline Stock Jumped 25% on Thursday
Why GlaxoSmithKline Stock Jumped 25% on Thursday
Motley Fool
GSK
spinoffs
Flag link:
GSK's consumer arm Haleon debuts with lacklustre valuation
GSK's consumer arm Haleon debuts with lacklustre valuation
Reuters
GSK
spinoffs
Haleon
consumer health
Flag link:
GSK has a chance to prove itself after next week's Haleon split. Will M&A follow?
GSK has a chance to prove itself after next week's Haleon split. Will M&A follow?
Fierce Pharma
GSK
spinoffs
Haleon
consumer health
M&A
Flag link:
GSK's consumer health spinoff Haleon will launch with 'significant' debt under its belt: report
GSK's consumer health spinoff Haleon will launch with 'significant' debt under its belt: report
Fierce Pharma
GSK
Haleon
spinoffs
consumer health
Flag link:
Novartis, staring down tough market for M&A, leans toward $25B Sandoz spinoff: Bloomberg
Novartis, staring down tough market for M&A, leans toward $25B Sandoz spinoff: Bloomberg
Fierce Pharma
Novartis
spinoffs
generics
M&A
Sandoz
private equity
Flag link:

Pages